The Blood concentration confirmation study on silymarin formulation of process materials.

The Blood concentration confirmation study on silymarin formulation of process materials. - The Blood concentration confirmation study on silymarin formulation of process materials.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022333

Enrollment

Registered

2016-05-17

Start date

2016-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Single ingestion of silymarin formulation of process materials Single ingestion of silymarin formulation of raw materials

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)Healthy males and females aged 20 to 50 years 2)BMI >=18.5 kg/m2 and <30kg/m2

Exclusion criteria

Exclusion criteria: 1)Subjects who previous serious disease. 2)Subjects who are taking medicine or being treated by a doctor 3)Subjects who previous or present serious disease that affect the digestion or being treated by a doctor because of the digestive tract disease 4)Subjects who plan to receive treatment or medication by a doctor during the study 5)Subjects who has chrysanthemum allergy 6)Subjects who use specified healthy food, supplement containing silymarin within the last one month prior to the current study 7)Subjects who cannot be performed over time blood collection 8)Subjects who are judged as unsuitable for the study by the investigator for other reason

Design outcomes

Primary

Measure	Time frame
Blood silymarin concentration after single ingestion of silymarin formulation	—

Countries

Japan

Contacts

Public ContactMasaya Tsubokawa

FANCL Corporation Research Institute

tsubokawa_masaya@fancl.co.jp045-820-3659

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026